Breaking News: @NutraPharma $NPHC – CEO @Rikdeitsch Interviewed by @StockGuruDotCom

Breaking News: @NutraPharma  $NPHC – CEO @Rikdeitsch Interviewed by @StockGuruDotCom

StockGuru Interview

Rik Deitsch – Chairman and CEO of Nutra Pharma  (OTCQB: NPHC)

 

 

Mobile users may listen using THIS LINK

 

About Rik Deitsch – from the Nutra Pharma website:

StockGuru Interview: Rik Deitsch – Chairman and CEO of Nutra Pharma (OTCQB: NPHC)Rik J. Deitsch has been the President, Chief Executive Officer and a Director of the Company since November 7, 2002. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic . Mr. Deitsch is an adjunct professor and teaches several courses for Florida Atlantic University’s College of Business and Continuing Education Department.

 

.

 

 

 

 

.

 

 

.

 

NPHC Disclosure: We hold not shares and will not be receiving any shares. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we don’t own shares, will not be buying shares and will not be selling shares. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. We expect to be compensated up to five thousand seven hundred dollars for coverage, assuming three months coverage. StockGuru – McKinney, Texas 75070 – (469) 358-5200.

Logo Header Menu